top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Autore Vermehren Charlotte
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (224 p.)
Soggetto topico Medicine
Pharmaceutical industries
Soggetto non controllato acute kidney injury
early biomarker
plasma neutrophil gelatinase-associated lipocalin
soluble urokinase plasminogen activator receptor
medication optimization
older patients
emergency department
multimorbidity
polypharmacy
potentially inappropriate medication use
older adults
prevalence
determinants
chronic
outpatient
2019 Beers criteria
Ethiopia
pharmacogenomics
persons with diabetes
drug–drug interactions
drug–gene interactions
cytochrome P450
SLCO1B1
drug interaction checkers
adverse drug reactions
pharmacogenetics
personalized medicine
phenprocoumon
DOACs
bleeding
thromboembolism
HLA
drug hypersensitivity
abacavir
allopurinol
flucloxacillin
antiepileptic drugs
cost-effectiveness
shared medication record
medication reconciliation
drug information service
hospital pharmacy service
electronic prescribing
electronic medical record
clinical pharmacist
CYP2D6
CYP2D7P
CYP2D8P
copy number variation
CNV
genotyping
5’nuclease assay
HRM
high resolution melting
drug metabolization
extracellular vesicles
exosomes
microvesicles
pharmacogene expression
medication review
deprescriptions
quality of life
aged
aged, 80 and over
nursing homes
deprescribing
medication-based risk score
health outcomes
cytochromes
CYP1A2
adverse drug reaction
antipsychotics
olanzapine
clozapine
loxapine
children
youth
digital decision-support
health services research
general practice
process evaluation
antidepressants
utility
population-based
appropriateness
medication adherence
digital health
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Record Nr. UNINA-9910595072903321
Vermehren Charlotte  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug-Drug Interactions
Drug-Drug Interactions
Autore Kim Dong Hyun
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (242 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato tadalafil
ticagrelor
drug-drug interaction
pharmacokinetics
plasma concentration
CYP3A4
Loxoprofen
CYP3A
Dexamethasone
Ketoconazole
CYP2D6
O-desmethyltramadol
physiologically-based pharmacokinetics
tramadol
(‒)-sophoranone
CYP2C9
potent inhibition
in vitro
in vivo
drug interaction
low permeability
high plasma protein binding
biflavonoid
cytochrome P450
drug interactions
selamariscina A
uridine 5′-diphosphoglucuronosyl transferase
tissue-specific
systemic exposure
P-glycoprotein (P-gp)
organic anion transporting polypeptide 1A2 (OATP1A2)
Rumex acetosa
fexofenadine
chronic kidney disease
drug–drug interactions
polypharmacy
adverse drug reactions
Lexicomp
subset analysis
signal detection algorithms
spontaneous reporting systems
mechanism-based inhibition
competitive inhibition
non-competitive inhibition
substrate
inhibitor
cytochromes P450
OATP1B1
OATP1B3
tyrosine kinase inhibitors
drug-drug interactions
migraine
lasmiditan
gepants
monoclonal antibodies
CYP1A1
CYP1A2
drug–drug interaction
expression
metabolism
regulation
drug transporter
ubiquitination
ixazomib
DDI
computational prediction
in silico
QSAR
drug metabolism
ADME
CYP
metabolic DDI
P450
1A2
2B6
2C19
2C8
2C9
2D6
3A4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557666403321
Kim Dong Hyun  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Innovation and Evidence for Achieving TB Elimination in the Asia-Pacific Region
Innovation and Evidence for Achieving TB Elimination in the Asia-Pacific Region
Autore DuCros Philipp
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (238 p.)
Soggetto topico Humanities
Social interaction
Soggetto non controllato pediatric TB
verbal screening
contact tracing
resources
sputum
health promotion
operational research
indigenous population
multidrug-resistant tuberculosis
household contact
screening
TB diagnosis
yield
operations research
contacts
contact investigation
MDR-TB
public-private mix model
public-private partnership
missing cases
SORT IT
TB diagnostics
laboratory methods
case detection
Xpert Ultra
STR
Bangladesh regimen
tuberculosis
post-tuberculosis morbidity and mortality
TB preventive therapy
latent TB infection
Asia Pacific
rifapentine-isoniazid
incidence
household contacts tracing
End TB
sustainable development goals
South-East Asia
Western Pacific Region
national TB program
socio-economic determinants
diabetes mellitus
TB-DM
adverse drug reactions
unfavourable outcome
lymph node TB
bone TB
TB elimination
extrapulmonary tuberculosis
private sector
intermediary agency
referral
notification
Viet Nam
active case finding
community outreach
Indonesia
key population
innovation
TB REACH
community health workers
mobile X-ray screening
TB
chest X-ray
active TB case-finding
diagnostic algorithm
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557609703321
DuCros Philipp  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Macular Edema: The Current Recommendations for Clinical Practice
Macular Edema: The Current Recommendations for Clinical Practice
Autore Maciej Gawęcki
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (128 p.)
Soggetto topico Medicine
Soggetto non controllato angiogenesis
angiopoietin-1
central serous chorioretinopathy
proangiogenic factors
combined treatment
subthreshold diode micropulse
anti-VEGF treatment
diabetic macular edema
retinal vein occlusion
Coats disease
peripheral retinal telangiectasia
laser photocoagulation
hypotony maculopathy
complications of antiglaucoma surgery
bleb compressive sutures
age-related macular degeneration
AMD
proteomics
tear film
tear film proteome
protein clearance
neovascularization
neovascular AMD
macular edema
uveitis
uveitic complications
non-steroidal anti-inflammatory drugs
steroids
biologic treatment
Irvine–Gass syndrome
cystoid macular edema
pseudophakic cystoid macular edema
NSAIDs corticosteroids
anti-VEGF
intravitreal injections
intravitreal agents
best corrected visual acuity
central retinal thickness
adverse drug reactions
intravitreal drug expenses
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Macular Edema
Record Nr. UNINA-9910557611003321
Maciej Gawęcki  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacogenetics to Avoid Adverse Drug Reactions
Pharmacogenetics to Avoid Adverse Drug Reactions
Autore López-Fernández Luis A
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (220 p.)
Soggetto topico Medicine
Soggetto non controllato 5-fluorouracil
capecitabine
fluoropyrimidine
thymidylate synthase
thymidylate synthase enhancer region
upstream stimulatory factor 1
adverse drug reactions
pharmacogenomics
epistasis
random forest
statin
cardiovascular disease
colorectal cancer
personalised medicine
toxicity
(es)citalopram
drug-gene-interaction
drug-drug-interaction
drug-drug-gene-interaction
the PharmLines initiative
antipsychotic agents
pharmacogenetics
cytochrome P-450 enzyme system
psychotic disorders
precision medicine
direct oral anticoagulants
clinical implementation
atorvastatin
SLCO1B1
HLA
cutaneous adverse drug reaction
SCAR
genetic polymorphism
antiepileptics
CYP450 enzymes
platelet reactivity
single-nucleotide variants
acute coronary syndrome
clopidogrel
genotype
allele
polymorphism
HLA B
CYP2C9*3
cutaneous adverse drug reactions (CADRs)
anti-epileptic drugs (AEDS)
phenytoin (PHT)
genetic risk factors
South India
India
cardiology
adverse events
guidelines
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557610103321
López-Fernández Luis A  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Precision Medicine : Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
Precision Medicine : Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
Autore Turgeon Jacques
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (170 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato fibromyalgia (FM)
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
microRNA
miRNome
pharmacogenomics
pharmacoepigenomics
SM2miR
Pharmaco-miR
repoDB
ME/CFS Common Data Elements (CDEs)
dihydropyrimidine dehydrogenase
DPYD
5-fluorouracil
fluoropyrimidine
therapeutic drug monitoring
orthotopic liver transplant
busulfan
glutathione S-transferase
genetic polymorphism
limited sampling strategy
pharmacokinetics
clinical pharmacogenetics
pharmacogenetic testing
adverse drug reactions
genotype
phenotype
pharmacogene
barriers to pharmacogenetics implementation
Sub-Saharan Africa
chronic low back pain (cLBP)
genetics
personalized treatment
polymorphism
CYP450
tacrolimus
CYP3A5
liver transplant
pharmacogenomic
minority
data collection
drug
biomarker
pharmacogenetics
pharmacogenetic test
personalized medicine
gene expression
infliximab
adalimumab
ulcerative colitis
Crohn disease
inflammatory bowel disease
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Precision Medicine
Record Nr. UNINA-9910585940803321
Turgeon Jacques  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui